Angiopoietin-like 3 Inhibitors [MoA] - N0000193916

Name: Table of NDC products with angiopoietin-like 3 inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193916
Pharmacologic Name	Angiopoietin-like 3 Inhibitors
Pharmacologic Uses	ANGPTL3 (angiopoietin-like 3) inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Angiopoietin-like 3 Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Angiopoietin-like 3 Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	61755-010	Evkeeza	Non-Proprietary Name: Evinacumab	Injection, Solution, Concentrate	Intravenous	Regeneron Pharmaceuticals, Inc.	ACTIVE
	61755-013	Evkeeza	Non-Proprietary Name: Evinacumab	Injection, Solution, Concentrate	Intravenous	Regeneron Pharmaceuticals, Inc.	ACTIVE